The Use of CD200 as a diagnostic marker in Egyptian patients with Chronic Lymphoproliferative Disorders
Last updated: 24 Dec 2024
10.21608/smj.2024.281984.1463
CD200, Flow cytometry, Non-Hodgkin lymphoma, Chronic lymphocytic leukemia, mantle cell lymphoma
FATEN
MOHAMED
ATEF
Akhmim Hospital Sohag Egypt
fatenatef782@gmail.com
Ahmed
Allam
A
Department of clinical and chemical pathology, Sohag Faculty of Medicine, Sohag University.
ahmed_farag@med.sohag.edu.eg
Sohag
Eman
Ali
H.
Department of clinical and chemical pathology, Sohag Faculty of Medicine, Sohag University.
eman_salama@med.sohag.edu.eg
Soahg
Tamer
Abdel-Latef
Department of Clinical and Chemical pathology, Sohag Faculty of Medicine, Sohag University.
tamer_soliman@med.sohag.edu.eg
Sohag
28
3
47914
2024-09-01
2024-04-08
2024-09-01
70
73
1687-8353
2682-4159
https://smj.journals.ekb.eg/article_365758.html
https://smj.journals.ekb.eg/service?article_code=365758
365,758
Original Article
785
Journal
Sohag Medical Journal
https://smj.journals.ekb.eg/
The Use of CD200 as a diagnostic marker in Egyptian patients with Chronic Lymphoproliferative Disorders
Details
Type
Article
Created At
24 Dec 2024